Cattle (heifers fed in confinement for slaughter)
Melengestrol acetate, 0.25 to 0.50 milligram per head per day, plus monensin (as monensin sodium) at 50 to 360 milligrams per head per day, plus tylosin (as tylosin phosphate), 90 milligrams per head per day. To attain these amounts:
Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate per pound to a medicated feed containing 5 to 30 grams of monensin and 8 to 10 grams of tylosin per ton; or;
Add 0.5 to 2.0 pounds per head per day of a liquid or dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate plus 25 to 720 milligrams of monensin per pound to 4.5 to 18 pounds of a dry medicated feed containing 10 to 40 grams of tylosin per ton; or;
Add 0.5 to 2.0 pounds per head per day of a dry medicated feed containing 0.125 to 1.0 milligram of melengestrol acetate (from a dry Type A article), 25 to 600 milligrams of monensin, plus 45 to 180 milligrams of tylosin per pound to a ration of non-medicated feed.
Oral
For heifers fed in confinement for slaughter.
MGA® 100 / Rumensin® / Tylan®
Cattle (heifers fed in confinement for slaughter)
Feed continuously as sole rotation containing 9.8 to 24.6 grams/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; combined with monensin 10 to 40 grams per ton to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day; tylosin 8 to 10 grams per ton to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 milligrams per head per day for the last 28 to 42 days on feed.
Oral
Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
Ractopamine HCl is not for animals intended for breeding.
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Special considerations: Mixing directions for liquid melengestrol acetate Type C feeds storedin recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tankto the top. Recirculate daily, as directed in this paragraph evenwhen the Type C feed is not used." For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems:“Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”
Heifermax™ / Optaflexx® / Rumensin® / Tylan®
Cattle (heifers fed in confinement for slaughter)
Complete feed: Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.
Oral
Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
Ractopamine HCl is not for animals intended for breeding.Special considerations:Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”
Optaflexx™ and Rumensin™ and Tylan™and MGA®
Cattle (heifers fed in confinement for slaughter)
Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin; mixed or top dressed with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate/head/day.
Oral
Feed continuously to cattle during the last 20 to 40 dayson feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine. Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.
Special considerations:1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.
Zilmax® and Rumensin™ and Tylan™ and MGA®
Cattle (heifers fed in confinement for slaughter)
Melengestrol acetate (0.125 to 1.0 mg/lb) is top dressed or mixed with a complete ration containing monensin (10-40 g/ton) and zilpaterol (6.8 g/ton).
Oral
Feed as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal.
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.
Heifermax® 500/Zilmax®/Rumensin®
Cattle (heifers fed in confinement for slaughter)
Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).
Oral
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.
Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
HeifermaX™ 500 / Rumensin™ / Tylan™
Cattle (Fed in Confinement for Slaughter)
Component Feed: Feed continuously to cattle during the last 20 to 40 days on feed, in a component feed containing 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride, In combination with: monensin, USP - 10 to 40 g/ton of feed to provide 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
Zilmax®/Rumensin®/MGA®
Cattle (Fed in Confinement for Slaughter)
Complete feed: Feed continuously to cattle during the last 20 to 40 days on feed as the sole ration, containing 6.8 g/ton zilpaterol to provide 60 to 90 mg zilpaterol hydrochloride per head per day, In combination with: monensin, USP - 10 to 40 g/ton of feed to provide 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
Zilmax®/Rumensin®/MGA®
Cattle (Fed in Confinement for Slaughter)
Component Feed: 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride during the last 20 to 40 days on feed, In combination with: monensin, USP- 10 to 40 g/ton monensin
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
3) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
4) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 4.3 to 7.1. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.
Zilmax® plus Rumensin®
Cattle (Fed in Confinement for Slaughter)
6.8 g/ton zilpaterol hydrochloride to provide 60 to 90 mg/head/per day zilpaterol hydrochloride during the last 20 to 40 days on feed,In combination with: monensin, USP- 10 to 40 g/ton monensin
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type B and Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thoroughly mixed in feeds before use. Do not feed undiluted. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
3) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
4) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. The liquid Type B feeds must be maintained at a pH of 4.3 to 7.1. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.
Zilmax® plus Rumensin®
Cattle (Heifers Fed in Confinement for Slaughter)
Component Feed: Feed continuously to cattle during the last 20 to 40 days on feed, in a component feed containing 6.8 to 24 g/ton zilpaterol hydrochloride to provide 60 mg/head/day zilpaterol hydrochloride, In combination with: monensin, USP - 10 to 40 g/ton of feed , and melengestrol acetate 0.5 to 2.0 lb/head/day of a feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day. Feed melengestrol acetate in this combination during the last 20 to 40 days on feed.
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
3) Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.
Zilmax®/Rumensin®/MGA®
Cattle (Heifers Fed in Confinement for Slaughter)
Complete feed: Feed continuously to cattle during the last 20 to 40 days on feed as the sole ration, containing 6.8 g/ton zilpaterol to provide 60 to 90 mg zilpaterol hydrochloride per head per day, monensin, USP - 10 to 40 g/ton of feed, and melengestrol acetate 0.5 to 2.0 lb/head/day of a feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day. Feed melengestrol acetate in this combination during the last 20 to 40 days on feed.
Oral
Feed continuously during the last 20 to 40 days on feed.
Special considerations:
1) Labeling of Type C cattle feeds shall bear the following: (i) Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. (ii) Zilpaterol hydrochloride is not for use in animals intended for breeding. (iii) Do not allow horses or other equines access to feed containing zilpaterol. (iv) Do not use in veal calves.
2) Labeling of Type C complete feeds must bear the following caution statement: CAUTION: Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
3) Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.
Zilmax®/Rumensin®/MGA®
Cattle (beef heifers fed in confinement for slaughter)
Melengestrol acetate (0.125 to 1.0 mg/lb) is top dressed or mixed with a complete ration containing monensin (10-40 g/ton) and ractopamine (9.8 to 24.6 g/ton).
Oral
Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.
Heifermax 500®/Optaflexx®/Rumensin®
Cattle (fed in confinement for slaughter)
Component Feed: 6.8 to 24 g/ton zilpaterol to provide 60 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin.
Oral
Feed continuously during the last 20 to 40 days on feed. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate aswell as elevated levels of creatine phosphokinase (CPK) and creatine.Special considerations:1) Labeling for Type B feeds used to manufacture Type C complete feeds must bear the caution statement: Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed.
2) Type B Liquid Feeds can be manufactured containing 68 to 680 g zilpaterol hydrochloride/ton. Inadequate mixing (recirculation or agitation) of monensin liquid Type B or Type C medicated feeds has resulted in increased monensin concentration, which has been fatal to cattle. For liquid feeds stored in recirculating tank systems: Recirculate immediately prior to use for not less than 10 minutes, moving not less than 1 percent of the tank contents per minute from the bottom of the tank to the top. Recirculate daily as described even when not used. For liquid feeds stored in mechanical, air or other agitation-type tank systems: Agitate immediately prior to use for not less than 10 minutes, creating turbulence at the bottom of the tank that is visible at the top. Agitate daily as described even when not used.3) All labeling for Type B and Type C feeds provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.
Zilmax® and Rumensin™ and Tylan™
Cattle (fed in confinement for slaughter)
Complete feed: 6.8 g/ton zilpaterol to provide 60 to 90 mg/head/day zilpaterol; 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg/lb body weight/day monensin, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day monensin; and 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin.
Oral
Feed continuously as sole ration during the last 20 to 40 days on feed. Do not allow horses or other equines access to feedscontaining monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90 percent dry matter basis), zilpaterol should not be fed in complete feed. Animals receiving zilpaterol hydrochloride may exhibit increased respiratory rate as well as elevated levels of creatine phosphokinase (CPK) and creatine.
Zilmax® and Rumensin™ and Tylan™
Cattle (growing beef heifers fed in confinement for slaughter)
0.25 to 2 g/ton of melengestrol acetate (as HeifermaX™) to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing monensin.
Oral
HeifermaX™ and Rumensin™
Cattle fed in confinement for slaughter
Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg monensin/head/day.Monensin is added to feedlot cattle diets at concentrations of 5 to 40 g of monensin USP per ton of complete feed for improved feed efficiency to provide 50 to 480 mg monensin/head/day.Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day.
Oral
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Rumensin® plus Tylovet® 100
Cattle fed in confinement for slaughter
568 to 757 g/ton of Pulmotil™ and 10 to 40 g/ton of Monovet®. To be fed continuously as the sole ration for a
single, 14 day period at 568 grams to 757 grams tilmicosin per ton on a 100% dry matter basis (511.2 to 681.3 g per ton on a 90% dry matter basis) to provide 12.5 mg tilmicosin/kg of body weight/day and 10 grams to 40 grams monensin per ton on a 90% dry matter basis (11.1 to 44.4 g per ton on a 100% dry matter basis) to provide 0.14 to 0.42 mg monensin/lb bodyweight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day.
Oral
Pulmotil™ and Monovet®
Cattle fed in confinement for slaughter
Not to exceed 800 g/ton Optaflexx™. Feed a minimum of 1.0 lb/hd/day Ractopamine Type C Top Dress TD + MT continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.
Oral
Optaflexx™and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
568 to 757 g/ton of Pulmotil™ and 5 to 40 g/ton of Monovet®. To be fed continuously as the sole ration for a single, 14 day period at 568 grams to 757 grams tilmicosin per ton on a 100% dry matter basis (511.2 to 681.3 g per ton on a 90% dry matter basis) to provide 12.5 mg tilmicosin/kg of body weight/day and 5 grams to 40 grams monensin per ton on a 90% dry matter basis (5.6 to 44.4 grams per ton on a 100% dry matter basis) to provide 50 to 480 mg monensin/head/day.
Oral
Pulmotil™ and Monovet®
Cattle fed in confinement for slaughter
Not to exceed 800 g/ton of Actogain™. Feed a minimum of 1.0 lb/head/day Ractopamine Type C Top Dress TD + M continuously to cattle fed in confinement for slaughter to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day.
Oral
Actogain™ and Monovet®
Cattle fed in confinement for slaughter
8.2 to 24.6 g/ton of Optaflexx™, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 70 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.
Oral
Optaflexx™and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
9.8 to 24.6 g/ton Optaflexx™, 10 to 40 g/ton Monovet®, and 8 to 10 g/ton Tylovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.
Oral
Optaflexx™and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
8.2 to 24.6 g/ton of Actogain™ and 10 to 40 g/ton of Monovet®. Feed continuously as sole ration to provide 70 to 430 mg/hd/day ractopamine as ractopamine HCl, and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day monensin for the last 28 to 42 days on feed.
Oral
Actogain™ and Monovet®
Cattle fed in confinement for slaughter
5 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 50 to 480 mg/hd/day monensin and 60 to 90 mg/hd/day tylosin. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).
Oral
Monovet® and Tylovet®
Cattle fed in confinement for slaughter
10 to 40 g/ton of Monovet® and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.
Oral
Monovet® and Tylovet®
Cattle fed in confinement for slaughter
10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
Not to exceed 800 g/ton feeding a minimum of 1.0 lb/head/day to provide 70 to 400 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.
Oral
Optigrid® and Monovet®
Cattle fed in confinement for slaughter
10 to 40 g/ton of Monovet®. Feed at a rate of 0.14 to 0.42 milligram per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day.
Oral
Actogain™ and Monovet®
Cattle fed in confinement for slaughter
8.2 to 24.6 g/ton to provide 70 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the last 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.
Oral
Feed a minimum of 1.0 lb/hd/day continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day (depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg/hd/day tylosin.
Optaflexx™ and Rumensin™ and Tylan™
Cattle fed in confinement for slaughter
8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the last 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and Tylovet®
Cattle fed in confinement for slaughter
Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin (10 to 40 g/ton), and tylosin phosphate (8 to 10 g/ton).
Oral
Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed.
Optaflexx™ and Rumensin™ and Tylan™
Cattle fed in confinement for slaughter
Monensin, 5 to 40 grams per ton of feed, plus tylosin 8 to 10 grams per ton of feed.
Oral
Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration to provide 50 to 480 monensin mg/hd/day and 60 to 90 tylosin mg/hd/day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).
Rumensin™ and Tylan™
Cattle Fed in Confinement for Slaughter
Tilmicosin phosphate - 568 to 757 g/ton Monensin – 10 to 40 g/ton 100% dry matter basis 90% dry matter basis
Oral
The safety of tilmicosin has not been established in cattle intended for breeding purposes. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin is not approved for use in calves intended to be processed for veal.
For cattle fed in confinement for slaughter, feed continuously for 14 days to provide 12.5 mg tilmicosin/kg/head/day. Feed at a rate of 0.14 to 0.42 milligram monensin per pound of body weight per day, depending upon the severity of challenge, up to maximum of 480 milligrams per head per day.
Pulmotil® 90 and Rumensin® 90
Cattle Fed in Confinement for Slaughter
Ractopamine hydrochloride top dress (not to exceed 800g/ton) plus monensin USP (10 to 40 g/ton).
Oral
Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.
Optaflexx™ plus Rumensin®
Cattle Fed in Confinement for Slaughter
Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton).
Oral
Feed continuously as sole ration for the last 28 to 42 days on ration. Not for animals intended for breeding. Do not use in calves to be processed for veal.
Optaflexx™ plus Rumensin®
Growing beef steers and heifers fed in confinement for slaughter
400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter
Feed as the sole ration to provide 22.7 mg of decoquinate per 100 lb. of body weight per day, 50 to 360 mg of monensin per head per day, and 60 to 90 mg tylosin (as tylosin phosphate) per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.
Oral
Deccox® and Rumensin™ and Tylovet®
Growing beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™
Growing beef steers and heifers fed in confinement for slaughter
Feed continuously in a complete feed 5 to 40 g/ton monensin on a 90% dry matter basis to provide 50 to 480 mg monensin per head per day. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 g/ton (360 mg monensin per head per day).
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Rumensin™ 90
Growing beef steers and heifers fed in confinement for slaughter
50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter
400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™ and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™. Feed continuously as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™
Growing beef steers and heifers fed in confinement for slaughter
Feed continuously (10 to 40 g/ton) to provide 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg of monensin per head per day.
Oral
Monovet® 90
Growing beef steers and heifers fed in confinement for slaughter
Feed complete feed (5 to 40 g/ton) continuously to growing finishing beef cattle to provide not less than 50 nor more than 480 mg monensin per head per day.
Oral
Monovet® 90
Growing beef steers and heifers fed in confinement for slaughter
50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter
Decoquinate:12.9 to 90.8 g/ton and Monensin: 5 to 30 g/ton
Oral
Feed as sole ration to provide 22.7 milligrams of decoquinate per 100 lbs of body weight per day and 50 to 360 milligrams of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard. Do not feed to cows producing milk for human consumption. A withdrawal period has not been established for this product in pre-ruminant calves. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds are safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusal and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Deccox® and Rumensin™
Heifers Fed in Confinement for Slaughter
9.8 to 24.6 grams per ton ractopamine combined with monensin 10 to 40 grams per ton, and melengestrol acetate to provide 0.25 to 0.5 milligrams per head per day.
Oral
Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding.
Optaflexx™ / Rumensin® / MGA®
Beef Cows
Feed continuously at 50 to 200 mg per head per day. Blend into a minimum of 1 pound of Type C medicated feed and either hand feed or mix into the total ration. Feed (other than the Type C medicated feed containing Rumensin) can be restricted to 95% (of normal requirements) when 50 mg of monensin activity is fed, and to 90% at 200 mg. Cows on pasture or in dry lot must receive a minimum of 1 pound of Type C medicated feed per head per day. Additionally, a minimum of 16 pounds (air-dry basis) of roughage such as silage, haylage, ammoniated straw, hay or equivalent feedstuffs should be fed in order to meet NRC recommendations for beef cows to gain 0.25 to 0.75 pounds per head per day. Standing, dried winter range forage may not be of adequate quality to result in improved e¬fficiency when supplemented with Rumensin. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Rumensin™ 90
Beef Cows
Feed at a rate of 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Rumensin™ 90
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers
Feed at the rate of not less than 50 nor more than 200 mg per head per day in not less than one pound of Type C Medicated Feed; or after the 5th day, feed at the rate of 400 mg per head per day every other day in not less than 2 pounds of Type C Medicated Feed. The monensin concentration in the Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.
Oral
Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.
Monovet® 90
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers
Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton.
During the first 5 days, cattle should receive 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed at a rate of 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed OR at a rate of 400 mg monensin per head per day every other day in a minimum of 2 pounds of Type C medicated feed.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Rumensin™ 90
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers
Feed this supplemental Type C medicated feed containing 15 to 400 g monensin per ton to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge. During the first 5 days, cattle should receive a maximum of 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, feed up to a maximum of 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Type C free-choice medicated feeds
All Type C free-choice medicated feeds containing Rumensin must be manufactured according to an FDA-approved formula/specification. When using a formula/specification published in the Code of Federal Regulations (CFR), a Medicated Feed Mill license is not required. Use of Rumensin in a proprietary formula/specification not published in the CFR requires prior FDA approval and a Medicated Feed Mill license.
Rumensin™ 90
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) or in a dry lot and Replacement beef and dairy heifers
Feed at a rate to provide 0.14 to 0.42 mg per pound body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. The monensin concentration in Type C Medicated Feed must be between 15 and 400 grams per ton. During the first 5 days, cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.
Oral
Free-Choice (Self-Fed) Medicated Feeds: All Free-choice medicated feeds must provide not less than 50 nor more than 200 mg monensin per head per day.
Monovet® 90
Calves (excluding veal calves)
Feed at a rate of 0.14 to 1.00 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg of monensin per head per day. The monensin concentration in Type C Medicated Feed must be between 10 and 200 g/ton.
Oral
Monovet® 90
Calves (excluding veal calves)
10 to 200 grams per ton of feed to provide 0.14 to 1.00 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg of monensin per head per day.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Rumensin™ 90
Dairy Cows
Total Mixed Rations (“complete feed”): Feed continuously to dry and lactating dairy cows a total mixed ration ("complete feed") containing 11 to 22 g/ton monensin on a 100% dry matter basis.
Component Feeding Systems (including top dress): Feed continuously to dry and lactating dairy cows a Type C Medicated Feed containing 11 to 400 g/ton monensin. The Type C Medicated Feed must be fed in a minimum of 1 pound of feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.
Oral
Monovet® 90
Dairy Cows
Total Mixed Ration (complete feed): Feed continuously 11 to 22 g/ton monensin on a 100% dry matter basis.
Component Feeding Systems (including top dress): Feed continuously 11 to 400 g/ton monensin in a minimum of 1 pound Type C medicated feed per cow per day to provide 185 to 660 mg/head/day monensin to lactating cows or 115 to 410 mg/head/day monensin to dry cows.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Feeding undiluted or mixing errors resulting in high concentrations of monensin has been fatal to cattle and could be fatal to goats. Must be thorougly mixed in feeds before use. Do not exceed the levels of monensin recommended in the feeding directions as reduced average daily gains may result. Do not feed to lactating goats. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. You may notice reduced voluntary feed intake in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. Rule out monensin as the cause of reduced feed intake before attributing to other causes such as illness, feed management, or the environment. You may notice reduced milk fat percentage in dairy cows fed monensin. This reduction increases with higher doses of monensin fed. You may notice increased incidence and treatment of cystic ovaries and metritis, reduced conception rates, increased services per animal, and extended days open and corresponding calving intervals in dairy cows fed monensin. Have a comprehensive and ongoing nutritional, reproductive and herd health program in place when feeding monensin to dairy cows.
Rumensin™ 90
Cattle (heifers fed in confinement for slaughter
Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).
Oral
Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicatedfeed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
MGA® and Rumensin™ and Tylan™
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter)
40 to 200 milligrams of monensin (0.25 to 1.13 pounds or 4 to 18 ounces of block) per head per day.
Oral
PASTURE GAINER BLOCK 20 R350 is a free-choice protein block containing 175 mg monensin per pound. Feed one block for every four (4) cattle. Place near watering or loafing areas in a well-drained area. Cattle should consume from 4.0 to 18.0 ounces (0.25 to 1.13 lb) per head per day to provide 40 to 200 mg monensin per head per day. Consumption of this block may vary with temperature and/or quality of forage. If consumption of the block is below 4.0 ounces per head per day, increase number of feeding locations or relocate the blocks to a more frequented area. Blocks should be replenished every 7 to 14 days. Do not allow cattle access to salt or minerals while being fed this block. Ingestion by cattle of monensin at levels of 600 mg per head per day and higher has been fatal. Do not allow horses or other equines access to feed containing monensin. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions; reduced average daily gains may result. Do not feed to sheep due to high levels of supplemental copper.
Pasture Gainer Block 20 R350
Cattle (pasture cattle: slaughter, stocker, feeder, and dairy and beef replacement heifers)
80 to 200 milligrams of monensin (0.2 to 0.5 pound of block) per head per day.
Oral
Block to be fed free choice. Provide at least 1 block per 5 head of cattle. Feed blocks continuously. Do not feed salt or minerals containing salt. Do not allow horses or other equines access to formulations containing monensin (ingestion of monensin by equines has been fatal). The effectiveness of this block in cull cows and bulls has not been established.
Sweetlix Rumensin® Pressed Block
Cattle (growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture)
MoorMan's Mintrate Red Block RU is for growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture when maintained on poor quality pasture or roughage or where pasture is in short supply. If the pasture or roughage is of good quality, Mintrate Blonde Block RU is recommended. Before feeding, be sure cattle are accustomed to protein blocks by feeding unmedicated Mintrate Blocks for 6 to 35 days or until cattle have demonstrated proper consumption. As soon as cattle have demonstrated proper consumption, remove the non-medicated blocks and replace with the recommended amount of Mintrate Red Block RU. Feed this block free-choice. Do not allow animals access to other protein blocks, salt or mineral while being fed this product. Recommended consumption of block is 0.34 to 1.33 lb per head per day to provide 50 to 200 mg monensin per head per day. A 10-day supply of blocks may be put out at one time. Place blocks near water or loafing areas. Not less than one block for each 10 to 12 animals is recommended. Additional blocks should be put out when the current blocks are 75% consumed.
Oral
MoorMan's® Mintrate® Red Block RU
Growing beef heifers fed in confinement for slaughter
0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day, 1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg lubabegron per head per day, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day, and 8 to 10 g/ton of tylosin (as tylosin phosphate) (as Tylan™) to provide 60 to 90 mg tylosin per head per day.
The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin and tylosin. Feed as the sole ration during the last 14 to 91 days on feed.
Oral
MGA® and Experior™ and Rumensin™ and Tylan™
Growing beef heifers fed in confinement for slaughter
0.25 to 2 g/ton of melengestrol acetate (as MGA® 200 or MGA® 500) to provide 0.25 to 0.5 mg melengestrol acetate per head per day; 1.25 to 4.54 g/ton of lubabegron (as Experior™) to provide 13 to 90 mg lubabegron per head per day; and 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing lubabegron and monensin. Feed as the sole ration during the last 14 to 91 days on feed.
Oral
MGA® and Experior™ and Monovet®
Growing beef heifers fed in confinement for slaughter
0.25 to 2 g/ton of melengestrol acetate (as CycleGuard®) to provide 0.25 to 0.5 mg melengestrol acetate per head per day and 10 to 40 g/ton of monensin (as Monovet®) to provide 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, up to a maximum of 480 mg monensin per head per day. The melengestrol acetate Type C top-dress medicated feed (0.5 to 2 lb(s) per head per day) must be top dressed onto or mixed at feeding with a Type C medicated feed containing monensin.
Oral
MGA® and Monovet®
Cattle (Heifer)
Melengestrol acetate (0.125 to 1. 0 mg/lb is top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton), and zilpaterol (6.8 g/ton).
Oral
Feed continuously as the sole ration for the final 20 to 40 days. Do not use in calves to be processed for veal. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feeds is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
Zilpaterol hydrochloride is not for use in animals intended for breeding. Do not allow horses or other equines access to feed containing zilpaterol. Do not use in veal calves. Not to be fed to cattle in excess of 90 mg zilpaterol/head/day in complete feed. If pen consumption of complete feed exceeds 26.5 lb/head/day (90% dry matter basis), zilpaterol should not be fed in complete feed.
Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days or more should be avoided to prevent the possibility that the heifers may come into estrus (heat) at loading time.
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Special considerations: 1) For liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.” 2) All labeling for Type C feeds containing zilpaterol hydrochloride provides the warning: The active ingredient in Zilmax® is zilpaterol hydrochloride, a beta2-adrenergic agonist. Not for use in humans. An anti-dust process has been applied to the drug product, Zilmax®, in order to greatly reduce inhalation risk. Extended handling tasks with the potential for dust generation require respiratory protection. Wear appropriate skin protection (e.g., impervious gloves, apron, overalls), if there is a potential for extended skin contact. Wear protective eyewear, if there is a potential for eye contact. If accidental eye contact occurs, immediately rinse with water and consult a physician.
Heifermax® 500/Zilmax®/Rumensin®/Tylan®
Cattle, Beef, Heifers fed in confinement for slaughter
Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin per ton of complete feed at a rate of 0.14 mg to 0.42 mg monensin per pound of body weight depending on the severity of coccidiosis challenge up to 480 mg per head per day.
Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin per head per day.
Oral
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Feed only to cattle being fed in confinement for slaughter. Feed continuously as sole ration. A withdrawal time has not been established in pre-ruminating calves. Do not use in calves to be processed for veal.
MGA®, Rumensin™ and Tylovet® 100
Cattle, Beef, Heifers fed in confinement for slaughter
Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine to provide 90 to 430 mg/hd/day ractopamine; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.
Oral
Melengestrol acetate is not effective in steers and spayed heifers. Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at time of loading. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Ractopamine HCl is not for animals intended for breeding.
Special considerations:
Mixing directions for liquid melengestrol acetate Type C feeds stored in recirculation tank systems, labeling indicates: “Recirculate immediately prior to use for no less than 10 minutes, moving not less than 1 percent of the tank contents from the bottom of the tank to the top. Recirculate daily, as directed in this paragraph even when the Type C feed is not used.” For liquid melengestrol Type C feeds stored in mechanical, air or other agitation-type tank systems: “Agitate immediately prior to use for not less than 10 minutes, creating a turbulence at the bottom of the tank that is visible at the top. Agitate daily, as directed in this paragraph, even when the Type C feed is not used.”
Optaflexx™ 45/Rumensin®/Tylovet® 100/MGA®
Cattle, Beef, Heifers fed in confinement for slaughter
Melengestrol acetate (0.25 to 2 g/ton) in combination with monensin (10 to 40 g/ton) and tylosin (8 to 10 g/ton).
Oral
Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.
Melengestrol acetate is for use only in heifers being fed in confinement for slaughter. Not effective in steers or spayed heifers. Heifers fed in confinement for slaughter: Withdrawal periods of three to five days should be avoided to prevent the possibility that the heifers may come into estrus (heat) at the time of loading.
Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feed is safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing.
Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite.
MGA®, Rumensin™ and Tylovet® 100
Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate.
Oral
Feed a minimum of 1.0 lb/hd/day Ractopamine Type C Top Dress TD + MT continuously to cattle fed in confinement for slaughter, to provide 70 to 400 mg/head/day ractopamine for the last 28 to 42 days on feed. Feed on top of a ration containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin phosphate, to provide 0.14 to 0.42 mg monensin/lb body weight/day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin.
Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding.
Actogain® and Rumensin™ and Tylan™
Ractopamine hydrochloride (9.8 to 24.6 g/ton) in combination with monensin sodium (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).
Oral
Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.
Actogain® and Rumensin™ and Tylan™
Heifers fed in confinement for slaughter
Ractopamine is fed continuously as the sole ration at a concentration of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed to provide 90 to 430 mg/hd/day ractopamine/head/day.
Monensin is added to the ration at a concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day of monensin for the last 28 to 42 days on feed.
Melengestrol acetate supplements (liquid and dry):
Must be top dressed or mixed with a complete ration containing ractopamine (9.8 to 24.6 g/ton) and monensin (10 to 40 g/ton). Feed at the rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg melengestrol acetate per head per day. Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.
Oral
Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.
Actogain® and Rumensin™ and MGA®
Heifers fed in confinement for slaughter
0.25 to 2 g/ton (0.0000276 to 0.00022%) of MGA®, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to heifers at a rate of 0.5 to 2.0 pounds per head per day to provide 0.25 to 0.5 mg/head/day melengestrol acetate and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day and 60 to 90 mg/head/day tylosin. The melengestrol acetate portion of this Type C medicated feed must be mixed into the complete feed containing 10 to 40 g/ton monensin and 8 to 10 g/ton tylosin at feeding into the amount of complete feed consumed by an animal per day.
Oral
MGA® and Monovet® and Tylovet®
Heifers fed in confinement for slaughter
Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine hydrochloride to provide 90 to 430 mg/head/day ractopamine hydrochloride, 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day (depending on severity of coccidiosis challenge, up to 480 mg/head/day), and 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.5 to 2.0 lb/head/day for the last 28 to 42 days on feed. The melengestrol acetate Type C medicated feed (fed at the rate of 0.5 to 2.0 lb/head/day) must be top dressed onto or mixed at feeding with Type C medicated feed containing ractopamine hydrochloride and monensin.
Oral
Optigrid® and Monovet® and CycleGuard®
Heifers fed in confinement for slaughter
Feed continuously as sole ration containing 9.8 to 24.6 g/ton ractopamine hydrochloride to provide 90 to 430 mg/head/day ractopamine hydrochloride; 10 to 40 g/ton monensin to provide 0.14 to 0.42 mg monensin/lb of body weight per day, depending on severity of coccidiosis challenge, up to 480 mg/head/day; 8 to 10 g/ton tylosin to provide 60 to 90 mg/head/day tylosin for the last 28 to 42 days on feed. Mix or top dress with medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound fed at the rate of 0.5 to 2.0 lb/head/day to provide 0.25 to 0.5 mg melengestrol acetate per head per day for the last 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and Tylovet® and CycleGuard®
Heifers fed in confinement for slaughter
0.125 to 1.0 mg/lb of MGA® for increased rate of weight gain, improved feed efficiency and suppression of estrus (heat) in heifers fed in confinement for slaughter. Must be top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton) and ractopamine (9.8 to 24.6 g/ton). Feed at the rate of 0.5-2.0 pound(s) per head per day (specify one level) to provide 0.25-0.5 mg melengestrol acetate per head per day (specify one level). Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.
Oral
Optaflexx™ and Monovet® and Tylan™ and MGA®
Heifers fed in confinement for slaughter
0.125 to 1.0 mg/lb of MGA®. Must be top dressed or mixed with a complete ration containing monensin (10 to 40 g/ton), tylosin (8 to 10 g/ton) and ractopamine (9.8 to 24.6 g/ton). Feed at the rate of 0.5-2.0 pound(s) per head per day (specify one level) to provide 0.25-0.5 mg melengestrol acetate per head per day (specify one level). Feed melengestrol acetate in this combination for the final 28 to 42 days on feed.
Oral
Optaflexx™ and Monovet® and Tylovet® and MGA®
Heifers fed in confinement for slaughter
9.8 to 24.6 g/ton of Optaflexx™, 10 to 40 g/ton of Monovet®, and 8 to 10 g/ton of Tylovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day and 60 to 90 mg/hd/day tylosin for the last 28 to 42 days on feed.
Oral
Optaflexx™ and Monovet® and Tylovet® and MGA®
Heifers fed in confinement for slaughter
9.8 to 24.6 g/ton of Actogain™ and 10 to 40 g/ton of Monovet®. Feed continuously as sole ration to provide 90 to 430 mg/hd/day ractopamine and 0.14 to 0.42 mg monensin/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/hd/day monensin for the last 28 to 42 days on feed.
Oral
Actogain™ and Monovet® and MGA®
Heifers fed in confinement for slaughter
10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of the coccidiosis challenge, up to 480 mg/head/day, of monensin (as Monovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and MGA®
Heifers fed in confinement for slaughter
0.125 to 1.0 mg/lb fed at the rate of 0.5 to 2.0 lb/head/day (specify one level) to provide 0.25 to 0.5 mg/head/day (specify one level) of melengestrol acetate (as MGA®). Feed continuously as sole ration for the final 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and MGA®
Heifers fed in confinement for slaughter
9.8 to 24.6 g/ton to provide 90 to 430 mg/head/day of ractopamine hydrochloride (as Optigrid®). Feed continuously as sole ration for the final 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and MGA®
Heifers fed in confinement for slaughter
8 to 10 g/ton to provide 60 to 90 mg/head/day of tylosin phosphate (as Tylovet®). Feed continuously as sole ration for the final 28 to 42 days on feed.
Oral
Optigrid® and Monovet® and Tylovet® and MGA®
Cattle, Beef heifers fed in confinement for slaughter
Ractopamine is fed at concentrations of 9.8 to 24.6 g of ractopamine hydrochloride per ton of complete feed (based on 90% dry matter basis) to provide 90 to 430 mg ractopamine/head/day in cattle fed in confinement for slaughter during the last 28 to 42 days on feed. Monensin is added to feedlot cattle diets at concentrations of 10 to 40 g of monensin USP per ton of complete feed at a rate of 0.14 to 0.42 mg monensin/lb of body weight, depending on severity of coccidiosis challenge, up to 480 mg/head/day. Tylosin is added to the cattle diets at concentrations of 8 to 10 g of tylosin phosphate per ton of complete feed to provide 60 to 90 mg tylosin/head/day. Melengestrol acetate is added to the diet of heifers at 0.5 to 2.0 pounds per head per day of medicated feed containing 0.125 to 1.0 mg melengestrol acetate per pound to provide 0.25 to 0.5 mg melengestrol acetate/head/day in heifers being fed for slaughter.
Oral
Feed continuously as sole ration during the last 28 to 42 days on feed. Not for animals intended for breeding. Do not use in calves to be processed for veal.Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Actogain™ 45/Rumensin®/Tylan®/MGA®
Cattle, Beef fed in confinement for slaughter
Ractopamine hydrochloride top dress (not to exceed 800 g/ton) to be fed with a ration containing 10 to 40 g/ton monensin in combination with 8 to 10 g/ton tylosin phosphate.
Oral
Feed continuously as sole ration during the last 28 to 42 days on feed. Do not use in calves to be processed for veal. Ractopamine HCl is not for animals intended for breeding. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Actogain™ 45/Rumensin®/Tylovet® 100
Cattle, Beef fed in confinement for slaughter
Ractopamine hydrochloride (8.2 to 24.6 g/ton) in combination with monensin USP (10 to 40 g/ton) and tylosin phosphate (8 to 10 g/ton).
Oral
Feed continuously as sole ration to provide 70 to 430 mg ractopamine per hd/day and 0.14 to 0.42 mg monensin per lb body weight/day (depending on severity of coccidiosis challenge, up to 480 mg/hd/day), and 60 to 90 mg tylosin per hd/day for the last 28 to 42 days on feed. Do not allow horses or other equines access to feeds containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle feed is safe for use in cattle only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result. If feed refusals containing monensin are fed to other groups of cattle, the concentration of monensin in the refusals and amount of refusals fed should be taken into consideration to prevent monensin overdosing. Do not use in any finished feed (supplement, concentrate or complete feed) containing in excess of 2% bentonite. Ractopamine HCl is not for animals intended for breeding. Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
Optaflexx™ 45/Rumensin®/Tylovet® 100
Growing beef steers and heifers on pasture (stocker, feeder, and slaughter) and replacement beef heifers on pasture
50 to 200 milligrams of monensin (2 to 8 ounces of block) per head per day.
Oral
Blocks to be fed free choice. Provide at least one block per five head of cattle. Feed blocks continuously. Discontinue feeding if block consumption falls below 2 oz. or rises above 8 oz daily. Do not feed salt or mineral supplements in addition to the blocks. Do not allow horses or other equines access to feed containing monensin. Ingestion of monensin by horses has been fatal. Monensin medicated cattle and goat feeds are safe for use in cattle and goats only. Consumption by unapproved species may result in toxic reactions. Do not exceed the levels of monensin recommended in the feeding directions, as reduced average daily gains may result
CATTLE BLOCK RU-MIN
Cattle (beef fed in confinement for slaughter)
Tilmicosin phosphate – 568 to 757 g/ton and monensin – 10 to 40 g/ton
Oral
The safety of tilmicosin has not been established in cattle intended for breeding purposes. Cattle intended for human consumption must not be slaughtered within 28 days of the last treatment with tilmicosin. Tilmicosin is not approved for use in female dairy cattle 20 months of age or older. Use in these cattle may cause drug residues in milk. Tilmicosin and monensin are not approved for use in calves intended to be processed for veal. A withdrawal period has not been established in pre-ruminating calves.
Tilmovet® 90 and Rumensin® 90
Beef cows
Feed continuously at a rate of 50 to 200 mg per head per day. Blend into a minimum of 1 pound of Type C Medicated Feed and either hand feed or mix into the total ration. Feed (other than the Type C Medicated Feed containing Monovet® 90) can be restricted to 95% (of normal requirements) when 50 mg of monensin activity is fed, and to 90% at 200 mg. Cows on pasture or in dry lot must receive a minimum of 1 pound of Type C Medicated Feed per head per day. Additionally, a minimum of 16 pounds (air-dry basis) of roughage such as silage, haylage, ammoniated straw, hay or equivalent feedstuffs should be fed in order to meet NRC recommendations for mature reproducing beef cows to gain 0.25 to 0.75 pounds per head per day. Standing, dried winter range forage may not be of adequate quality to result in improved efficiency when supplemented with Monovet® 90. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed. Do not self feed.
Oral
Monovet® 90
Beef cows
Feed at a rate of 0.14 to 0.42 mg per pound of body weight per day, depending upon severity of challenge, up to a maximum of 200 mg per head per day. During the first 5 days, pastured cattle should receive no more than 100 mg per day contained in not less than 1 pound of feed.
Oral
Monovet® 90
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, ofmonensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Monovet® and Tylovet®
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™
Feed continuously as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™ and Tylan™
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 10 to 40 g/ton to provide 0.14 to 0.42 mg/lb body weight per day, depending upon severity of coccidiosis challenge, up to 480 mg/hd/day, of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Monovet®
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™), 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®), and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of tylosin (as Tylovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Monovet® and Tylovet®
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of Experior™; 5 to 40 g/ton to provide 50 to 480 mg/hd/day of Rumensin™; and 8 to 10 g/ton to provide 60 to 90 mg/hd/day of Tylan™.
Feed continuously as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™ and Tylan™
Beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton to provide 13 to 90 mg/hd/day of lubabegron (as Experior™) and 5 to 40 g/ton to provide 50 to 480 mg/hd/day of monensin (as Monovet®). Feed continuously as the sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Monovet®
Growing beef heifers and heifers fed in confinement for slaughter
12.9 to 90.8 g/ton of decoquinate and 5 to 30 g/ton of monensin. Feed as the sole ration to provide 22.7 of mg decoquinate per 100 lb of body weight per day and 50 to 360 mg of monensin per head per day. Feed for at least 28 days during periods of coccidiosis exposure or when experience indicates that coccidiosis is likely to be a hazard.
Oral
Deccox® and Monovet®
Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter
10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration for not more than 5 days, then continue feeding monensin Type C medicated feed alone. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).
Oral
Pennchlor® and Rumensin™
Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter
10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of the coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Rumensin™
Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter
10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 1.00 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 200 mg/head/day of monensin. Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Rumensin™
Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter
0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 50 to 480 mg/head/day of monensin (as Rumensin™). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams/ton (360 mg monensin per head per day).
Oral
Pennchlor® and Rumensin™
Beef calves 2 months of age and older, and growing beef steers and heifers fed in confinement for slaughter
0.5 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™) to provide, depending upon severity of coccidiosis challenge, up to 480 mg/head/day of monensin. Feed as the sole ration.
Oral
Pennchlor® and Rumensin™
Replacement beef and dairy heifers
400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 84 g/ton of monensin (as Monovet®).
For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.
For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 0.14 to 0.42 mg monensin per pound of body weight per day, depending upon severity of challenge, to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Monovet®
Replacement beef and dairy heifers
400 to 2,000 g/ton of chlortetracycline (as Pennchlor®) and 15 to 400 g/ton of monensin (as Monovet®).
For replacement beef and dairy heifers not currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 100 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed.
For replacement beef and dairy heifers currently being fed monensin: feed as the sole ration for not more than 5 days to provide 10 mg chlortetracycline per pound of body weight per day and 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. After 5 days, continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Monovet®
Replacement beef and dairy heifers
10 mg/lb body weight/day of chlortetracycline (as Pennchlor®) and 0.14 to 0.42 mg/lb body weight/day of monensin (as Rumensin™), depending upon severity of challenge, to provide 50 to 100 mg/head/day of monensin. Feed in a minimum of 1 pound of Type C medicated feed as the sole ration for not more than 5 days. For replacement beef and dairy heifers not currently being fed monensin, continue to feed monensin Type C medicated feed alone to provide 50 to 200 mg monensin per head per day in a minimum of 1 pound of Type C medicated feed. For replacement beef and dairy heifers currently being fed monensin, continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Rumensin™
Beef calves 2 months of age and older
400 to 2000 g/ton of chlortetracycline (as Pennchlor®) and 10 to 200 g/ton of monensin (as Monovet®). Feed as the sole ration for not more than 5 days, then continue to feed monensin Type C medicated feed alone.
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter over 700 lbs
33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter over 700 lbs
33.33 to 66.67 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter over 400 lbs
7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 5 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter over 400 lbs
7 to 17.5 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter under 700 lbs
50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 7.14 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration. No additional improvement in feed efficiency has been shown from feeding monensin at levels greater than 30 grams per ton (360 mg monensin per head per day).
Oral
Pennchlor® and Monovet®
Growing beef steers and heifers fed in confinement for slaughter under 700 lbs
50 to 117 g/ton of chlortetracycline (as Pennchlor®) and 10 to 40 g/ton of monensin (as Monovet®). Feed as the sole ration.
Oral
Pennchlor® and Monovet®
Cattle/growing beef steers and heifers fed in confinement for slaughter
8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 400 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed a minimum of 1.0 lb per head per day of this Type C top-dress medicated feed during the last 28 to 42 days on feed.
Oral
Optaflexx™ and Rumensin™ and V-Max®
Cattle/growing beef steers and heifers fed in confinement for slaughter
8.2 to 24.6 g/ton of ractopamine hydrochloride (as Optaflexx™) to provide 70 to 430 mg/head/day of ractopamine hydrochloride, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed at every feeding as a sole ration during the last 28 to 42 days on feed.
Oral
Optaflexx™ and Rumensin™ and V-Max®
Cattle/growing beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed at every feeding as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™ and V-Max®
Cattle/growing beef steers and heifers fed in confinement for slaughter
1.25 to 4.54 g/ton of lubabegron (as lubabegron fumarate) (as Experior™) to provide 13 to 90 mg/head/day of lubabegron, 5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin, and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed at every feeding as sole ration during the last 14 to 91 days on feed.
Oral
Experior™ and Rumensin™ and V-Max®
Cattle/growing beef steers and heifers fed in confinement for slaughter
10 to 40 g/ton of monensin (as Rumensin™) to provide 0.14 to 0.42 mg/lb body weight per day, depending on the severity of coccidiosis challenge, up to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed at every feeding.
Oral
Rumensin™ and V-Max®
Cattle/growing beef steers and heifers fed in confinement for slaughter
5 to 40 g/ton of monensin (as Rumensin™) to provide 50 to 480 mg/head/day of monensin and 13.5 to 16 g/ton of virginiamycin (as V-Max®) to provide 85 to 240 mg/head/day of virginiamycin.
Feed at every feeding.
Oral
Rumensin™ and V-Max®